Planetmed Sp. z o.o.
Wroclaw 53-333
3 studies enrolling now · 11 studies all time
What they study most
Crohn Disease, Crohn's Disease, Fibrostenotic Crohn's Disease, Primary Biliary Cholangitis, Primary Biliary Cholangitis (PBC), Ulcerative Colitis, Ulcerative Colitis Chronic
Studies at this site
- A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis — Recruiting now
- A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis — Recruiting now
- Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
- STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease — Completed
- A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
- A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
- An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
- A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. — Completed
- A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease — Completed
- A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease — Completed